VIC regimen (vemurafenib/irinotecan/cetuximab) versus bevacizumab plus chemotherapy as first-line treatment for BRAF V600E-mutated advanced colorectal cancer. This is ...
Evaluation of circulating-tumor DNA (ctDNA) as a source material for molecular phenotyping of colorectal tumors. This is an ASCO Meeting Abstract from the 2015 Gastrointestinal Cancers Symposium. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results